Covid 19 Virus Articles & Analysis: Older
45 news found
Jamie Triccas) which, together with ExcellGene, constitutes a three – party consortium funded by CEPI with a grant of 19 million US dollars. The project has the goal to develop a “Pan-protective SARS-CoV-2 vaccine” hoping to show protection against all past and future variant of concern of the Corona virus. Initiated 2020 by ExcellGene’s ...
Alertgy plans to focus on non-invasive glucose monitoring of non-insulin dependent Type 2 diabetics and pre-diabetics during its FDA clinical trials. COVID Detection Alertgy’s patented RF sensor technology has the potential to detect molecules other than glucose, both inside the body and in lab-based settings. For this reason, Alertgy is partnering with Florida Atlantic ...
ByAlertgy
The ongoing COVID-19 pandemic necessitates the need for robust and reliable detection methods to tackle the spread of the virus and to alleviate the severe socio-economic consequences of the disease. Alertgy has partnered with Florida Atlantic University’s (FAU) Immunology and Virology Department to execute a collaborative study on the ...
ByAlertgy
In the past year miDiagnostics has been working on the development of an ultra-fast PCR test based on imec technology, to detect COVID-19, with a test result in less than 15 minutes. In cooperation with Brussels Airport, this nasal-swab ultra-fast PCR test, as well as the new breath sampler developed by imec and licensed by miDiagnostics, will be tested in ...
In November 2021, the company was awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative of the SARS-CoV-2 / COVID-19 virus. ...
The planned clinical site in Serbia will not be participating in the study due to staffing capacity issues related to the ongoing impact of the COVID-19 virus. “We are pleased that the initial safety data from InMed’s Phase 2 EB clinical trial has allowed the inclusion of adolescent patients,” stated Alexandra Mancini, Senior ...
EPA recommends the use of disinfectants to inactivate the SARS-CoV-2 (COVID-19) virus. Matter-of-factly, QACs are active ingredients in over 200 disinfectants. ...
Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the ...
The analysis found that participants receiving a booster dose saw a significant increase in neutralizing titers, an important predictor of vaccine efficacy. “As the COVID-19 virus continues to evolve, so does our understanding of the efficacy of vaccines and the critical role they play in protecting people from serious disease, ...
The Agreement is for an initial pre-order of 10 million doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments. ...
(www.ora-vax.com), has screened and enrolled the first participant in a Phase 1 clinical trial of its oral virus-like particle (VLP) COVID-19 vaccine in Johannesburg, South Africa. The open-label trial anticipates enrolling 24 participants who have not received either a COVID-19 vaccine or contracted the ...
Emergency rations. And, just maybe, some future COVID-19 vaccines. Freeze-drying is a method for removing water from a product. ...
This route mimics the natural infection pathway of the respiratory virus COVID-19 and may create additional benefits through generating mucosal immunity. ...
ByAerogen
The funding will accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative of the SARS-CoV-2 / COVID-19 virus. Currently in clinical trials in the U.S., Anavasi expects to file its submission to the U.S. ...
As we all know, this has been a special year for everyone. This difficult period is making us experience new situations and emotions that until recently we would never have ...
For the time being, we are doing our best to help limiting the spread of the Corona virus (COVID-19) in Germany and globally. Actually, there is no Corona virus infection known within our company. ...
According to the World Health Organization, “People in close contact with someone who is infected with a virus, such as the Ebola or COVID virus, are at higher risk of becoming infected themselves, and of potentially further infecting others. ...
ByBioVigil
The COVID-19 pandemic has wreaked havoc across the globe. As of July 30, 2021, nearly 197.5 million people have been infected with coronavirus, and 4.2 million people have died. The COVID-19 pandemic has resulted in significant pressure on healthcare systems around the globe. ...
ByJADBio
This number was set to increase by 6% year on year before the onset of COVID-19, however the increase in patients will now likely be higher given the long-term damage that the virus can wreak on patients’ kidneys. For particularly ill patients with COVID-19, the virus can cause acute kidney ...
The University of Oregon tests were performed in quarantine and isolation spaces known to have individuals who had tested positive for SARS-CoV-2 (the virus causing COVID-19). The BioFlash identified aerosolised virus, at the detectable range generated via human shedding, in rooms where the presence of SARS-CoV-2 was also ...